Rudolf Weide

1.9k total citations
89 papers, 1.0k citations indexed

About

Rudolf Weide is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Rudolf Weide has authored 89 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 22 papers in Genetics. Recurrent topics in Rudolf Weide's work include Chronic Lymphocytic Leukemia Research (21 papers), Lymphoma Diagnosis and Treatment (20 papers) and Cancer Treatment and Pharmacology (13 papers). Rudolf Weide is often cited by papers focused on Chronic Lymphocytic Leukemia Research (21 papers), Lymphoma Diagnosis and Treatment (20 papers) and Cancer Treatment and Pharmacology (13 papers). Rudolf Weide collaborates with scholars based in Germany, United States and United Kingdom. Rudolf Weide's co-authors include H. Köppler, Jochen Heymanns, Jörg Thomalla, K. Havemann, W. Lorenz, Eduard M. Walthers, K. Ehlenz, Martine Klausmann, C. Dowding and J. M. Goldman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rudolf Weide

85 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rudolf Weide Germany 19 488 344 331 236 198 89 1.0k
H. Köppler Germany 19 382 0.8× 283 0.8× 297 0.9× 128 0.5× 211 1.1× 66 872
Raúl Córdoba Spain 20 549 1.1× 255 0.7× 434 1.3× 128 0.5× 157 0.8× 131 1.2k
Igor Aurer Croatia 20 449 0.9× 223 0.6× 531 1.6× 187 0.8× 170 0.9× 88 950
Astrid Franke Germany 13 403 0.8× 392 1.1× 641 1.9× 154 0.7× 141 0.7× 28 1.0k
B. W. Hancock United Kingdom 16 487 1.0× 203 0.6× 434 1.3× 148 0.6× 78 0.4× 52 1.3k
Canellos Gp United States 20 361 0.7× 412 1.2× 477 1.4× 160 0.7× 516 2.6× 49 1.3k
Yasser Khafaga Saudi Arabia 20 454 0.9× 226 0.7× 345 1.0× 300 1.3× 61 0.3× 49 1.3k
Alessia Bari Italy 19 449 0.9× 179 0.5× 550 1.7× 119 0.5× 179 0.9× 53 911
R H Herzig United States 15 368 0.8× 325 0.9× 217 0.7× 174 0.7× 636 3.2× 27 1.1k
Frank B. Cortazar United States 16 594 1.2× 222 0.6× 146 0.4× 602 2.6× 55 0.3× 40 1.3k

Countries citing papers authored by Rudolf Weide

Since Specialization
Citations

This map shows the geographic impact of Rudolf Weide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf Weide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf Weide more than expected).

Fields of papers citing papers by Rudolf Weide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudolf Weide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf Weide. The network helps show where Rudolf Weide may publish in the future.

Co-authorship network of co-authors of Rudolf Weide

This figure shows the co-authorship network connecting the top 25 collaborators of Rudolf Weide. A scholar is included among the top collaborators of Rudolf Weide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rudolf Weide. Rudolf Weide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weide, Rudolf, et al.. (2024). Metastatic Breast Cancer: Prolonging Life in Routine Oncology Care. Cancers. 16(7). 1255–1255. 1 indexed citations
2.
Otremba, Burkhard, et al.. (2024). Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen. International Journal of Clinical Pharmacology and Therapeutics. 62(6). 241–249. 1 indexed citations
3.
Brucker, Cosima, Thomas Decker, PA Fasching, et al.. (2023). 441P Real-world efficacy of ribociclib (RIB) + aromatase inhibitor (AI)/fulvestrant (FUL) in subgroups of special interest: 5th interim analysis (IA) of the RIBANNA study. Annals of Oncology. 34. S366–S367. 1 indexed citations
4.
5.
6.
Laakmann, Elena, Elisa Agostinetto, Francesco Schettini, et al.. (2023). 208P Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases: A subanalysis of the German brain metastases in breast cancer registry (BMBC). ESMO Open. 8(1). 101397–101397. 1 indexed citations
7.
Laakmann, Elena, Tjoung‐Won Park‐Simon, Rudolf Weide, et al.. (2022). Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC Registry. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 19(2). e34–e35. 1 indexed citations
8.
Laakmann, Elena, Tanja Neunhöffer, Rudolf Weide, et al.. (2022). 170P Long-term survival of breast cancer patients with brain metastases: Subanalysis of the BMBC registry. Annals of Oncology. 33. S202–S203. 1 indexed citations
9.
Heymanns, Jochen, et al.. (2016). Follow-up Reality for Breast Cancer Patients – Standardised Survey of Patients and Physicians and Analysis of Treatment Data. Geburtshilfe und Frauenheilkunde. 76(5). 557–563. 9 indexed citations
10.
Weide, Rudolf, et al.. (2015). Outpatient Management of Patients with Immune Thrombocytopenia (ITP) by Hematologists 1995-2014. Oncology Research and Treatment. 39(1-2). 41–44. 14 indexed citations
11.
Weide, Rudolf, et al.. (2014). Metastatic breast cancer: prolongation of survival in routine care is restricted to hormone-receptor- and Her2-positive tumors. SpringerPlus. 3(1). 535–535. 34 indexed citations
12.
13.
Heymanns, Jochen, et al.. (2010). Evaluation of psychosocial distress in patients treated in a community-based oncology group practice in Germany. Annals of Oncology. 22(4). 931–938. 26 indexed citations
14.
15.
Köppler, H., et al.. (2004). Bendamustine Plus Mitoxantrone—A New Effective Treatment for Advanced Chronic Lymphocytic Leukaemia: Results of a Phase I/II Study. Leukemia & lymphoma. 45(5). 911–913. 26 indexed citations
16.
Weide, Rudolf, et al.. (2003). Chronische Bleivergiftung durch ayurvedische Heilpillen. DMW - Deutsche Medizinische Wochenschrift. 128(46). 2418–2420. 7 indexed citations
17.
Weide, Rudolf, et al.. (1996). Storage of noncryopreserved periphered blood stem cells for transplantation. Annals of Hematology. 72(5). 303–306. 19 indexed citations
18.
Weide, Rudolf, Jochen Heymanns, H. Köppler, et al.. (1994). Successful treatment of neutropenia in T-LGL leukemia (Tγ-lymphocytosis) with granulocyte colony-stimulating factor. Annals of Hematology. 69(3). 117–119. 9 indexed citations
19.
Weide, Rudolf, Behnoush Parviz, K.-H. Pflüger, & K. Havemann. (1993). Altered expression of the human retinoblastoma gene in monocytic leukaemias. British Journal of Haematology. 83(3). 428–432. 18 indexed citations
20.
Weide, Rudolf, et al.. (1990). Multiple myeloma of the bladder and vagina. Cancer. 66(5). 989–991. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Köppler Breakdown of academic impact, for papers by Raúl Córdoba Breakdown of academic impact, for papers by Igor Aurer Breakdown of academic impact, for papers by Astrid Franke Breakdown of academic impact, for papers by B. W. Hancock Breakdown of academic impact, for papers by Canellos Gp Breakdown of academic impact, for papers by Yasser Khafaga Breakdown of academic impact, for papers by Alessia Bari Breakdown of academic impact, for papers by R H Herzig Breakdown of academic impact, for papers by Frank B. Cortazar
Rankless by CCL
2026